Longitudinal Study of Neurodegenerative Disorders

NCT03333200 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-02-09

No results posted yet for this study

Summary

The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understanding of the progression of the rare neurodegenerative disorders and the effects of interventions.

Conditions

  • MLD
  • Krabbe Disease
  • ALD
  • MPS I
  • MPS II
  • MPS III
  • Vanishing White Matter Disease
  • GM3 Gangliosidosis
  • PKAN
  • Tay-Sachs Disease
  • NP Deficiency
  • Osteopetrosis
  • Alpha-Mannosidosis
  • Sandhoff Disease
  • Niemann-Pick Diseases
  • MPS IV
  • Gaucher Disease
  • GAN
  • GM1 Gangliosidoses
  • Morquio Disease
  • S-Adenosylhomocysteine Hydrolase Deficiency
  • Batten Disease
  • Pelizaeus-Merzbacher Disease
  • Leukodystrophy
  • Lysosomal Storage Diseases
  • Purine Nucleoside Phosphorylase Deficiency
  • Multiple Sulfatase Deficiency Disease

Interventions

OTHER

Palliative Care

Collecting information about the natural progression of these diseases

BIOLOGICAL

Hematopoetic Stem Cell Transplantation

Following patients who have received HSCT as part of their clinical care.

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-11
Primary Completion
2030-01-31
Completion
2035-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03333200 on ClinicalTrials.gov